- Report
- July 2022
- 120 Pages
North America
From €3044EUR$3,450USD£2,633GBP
- Report
- July 2022
- 132 Pages
Europe
From €3044EUR$3,450USD£2,633GBP
- Report
- July 2022
- 122 Pages
United Kingdom
From €3044EUR$3,450USD£2,633GBP
- Report
- March 2022
- 198 Pages
Global
From €3927EUR$4,450USD£3,396GBP
- Report
- September 2023
- 89 Pages
From €2603EUR$2,950USD£2,251GBP
- Report
- September 2023
- 107 Pages
Asia Pacific
From €3044EUR$3,450USD£2,633GBP
- Report
- September 2023
- 101 Pages
North America
From €2603EUR$2,950USD£2,251GBP
- Report
- September 2023
- 194 Pages
Global
From €4368EUR$4,950USD£3,778GBP
- Report
- August 2025
- 105 Pages
Global
From €3500EUR$4,249USD£3,133GBP
- Report
- November 2024
- 78 Pages
Global
From €3500EUR$4,249USD£3,133GBP
The Travel Vaccine market is a subset of the Vaccine market, focusing on vaccines that are recommended for travelers. These vaccines are typically recommended for those who are traveling to areas with a higher risk of certain diseases, such as yellow fever, typhoid, and hepatitis A and B. Travel vaccines are typically administered by a healthcare provider, and may require multiple doses over a period of time.
The Travel Vaccine market is a growing sector, with an increasing number of travelers seeking protection from diseases that may be present in their destination countries. Vaccines are also becoming more widely available, with many countries now offering travel vaccines as part of their public health programs.
Some companies in the Travel Vaccine market include Sanofi Pasteur, GlaxoSmithKline, Merck, Pfizer, and Novartis. Show Less Read more
